News tagged with myeloid leukemia
Some leukemia patients may be able to safely stop treatment
(PhysOrg.com) -- New medical trials suggest some chronic leukemia patients who are in complete remission may be cured by the standard drug used to treat the condition and can safely discontinue its use.
Oct 21, 2010 |
4.2 / 5 (5) |
1
|
Researchers discover the processes leading to acute myeloid leukemia
Researchers at UC Santa Barbara have discovered a molecular pathway that may explain how a particularly deadly form of cancer develops. The discovery may lead to new cancer therapies that reprogram cells instead ...
Jan 30, 2012 |
5 / 5 (1) |
0
|
Lessons learned from yeast about human leukemia
The trifecta of biological proof is to take a discovery made in a simple model organism like baker's yeast and track down its analogs or homologs in "higher" creatures right up the complexity scale to people, ...
Dec 05, 2011 |
5 / 5 (2) |
0
|
Decoding cancer patients' genomes is powerful diagnostic tool
Two new studies highlight the power of sequencing cancer patients' genomes as a diagnostic tool, helping doctors decide the best course of treatment and researchers identify new cancer susceptibility mutations ...
Apr 19, 2011 |
3 / 5 (1) |
0
|
New evidence of stem cells' pivotal role in cancer shown
Leukemia patients whose cancers express higher levels of genes associated with cancer stem cells have a significantly poorer prognosis than patients with lower levels of the genes, say researchers at the Stanford University ...
Dec 21, 2010 |
5 / 5 (3) |
1
|
Researchers discover key mutation in acute myeloid leukemia
Researchers have discovered mutations in a particular gene that affects the treatment prognosis for some patients with acute myeloid leukemia (AML), an aggressive blood cancer that kills 9,000 Americans annually. ...
Nov 11, 2010 |
3 / 5 (2) |
0
|
Protein that predicts prognosis of leukemia patients may also be a therapeutic target
Researchers at Whitehead Institute and Children's Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) patients.
Medicine & Health / Medical research
Jul 08, 2010 |
5 / 5 (1) |
0
|
Researchers find genetic link to leukemias with an unknown origin
Although leukemia is one of the best studied cancers, the cause of some types is still poorly understood. Now, a newly found mutation in acute myeloid leukemia patients could account for half of the remaining ...
Feb 18, 2010 |
5 / 5 (4) |
0
|
Drug that modifies gene activity could help some older leukemia patients
Older patients with acute myeloid leukemia (AML) might benefit from a drug that reactivates genes that cancer cells turn off, according to research at Washington University School of Medicine in St. Louis and collaborating ...
Jan 12, 2010 |
not rated yet |
0
|
Doubling chemo dose helped leukemia patients
(AP) -- Adults with a common form of leukemia had a better chance of remission if they got a double dose of a long-used cancer drug, two new studies found.
Sep 23, 2009 |
5 / 5 (2) |
0
Study finds promise in combined transplant/vaccine therapy for high-risk leukemia
(PhysOrg.com) -- Two of the most powerful approaches to cancer treatment -- a stem cell transplant and an immune system-stimulating vaccine -- appear to reinforce each other in patients with an aggressive, ...
Aug 24, 2009 |
not rated yet |
0
Disrupting a destructive duo: Researchers inhibit cancer proteins
A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side ...
Aug 20, 2009 |
5 / 5 (1) |
0
Comprehensive look at rare leukemia finds relatively few genetic changes launch disease
The most comprehensive analysis yet of the genome of childhood acute myeloid leukemia (AML) found only a few mistakes in the genetic blueprint, suggesting the cancer arises from just a handful of missteps, according to new ...
Jul 27, 2009 |
not rated yet |
0
Controversial cancer stem cells offer new direction for treatment (w/ Video)
In a review in Science, a University of Rochester Medical Center researcher sorts out the controversy and promise around a dangerous subtype of cancer cells, known as cancer stem cells, which seem capable of res ...
Jun 25, 2009 |
5 / 5 (1) |
2
Stem cell protein offers a new cancer target
A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.
Jun 01, 2009 |
not rated yet |
0
